Updates are available Erratum dated 2016-10-27
Click to view Erratum: https://doi.org/10.1038/ncb3428
-
Authors
Planas-Paz, Lara
Orsini, Vanessa
Boulter, Luke http://orcid.org/0000-0002-7954-6705
Calabrese, Diego http://orcid.org/0000-0002-0259-8611
Pikiolek, Monika
Nigsch, Florian
Xie, Yang
Roma, Guglielmo
Donovan, Adriana
Marti, Patricia
Beckmann, Nicolau
Dill, Michael T.
Carbone, Walter
Bergling, Sebastian
Isken, Andrea
Mueller, Matthias
Kinzel, Bernd
Yang, Yi
Mao, Xiaohong
Nicholson, Thomas B.
Zamponi, Raffaella
Capodieci, Paola
Valdez, Reginald
Rivera, Daniel
Loew, Andreas
Ukomadu, Chinweike
Terracciano, Luigi M.
Bouwmeester, Tewis
Cong, Feng
Heim, Markus H. http://orcid.org/0000-0002-7523-4894
Forbes, Stuart J.
Ruffner, Heinz
Tchorz, Jan S.
- License Information
-
More Information
Article History
Received: 19 October 2015
Accepted: 10 March 2016
First Online: 18 April 2016
Change Date: 27 September 2016
Change Type: Correction
Change Details: In the version of this Article originally published, the authors inadvertently omitted a key reference. The following reference has been added: '48. Rocha, A. S. et al. The angiocrine factor Rspondin3 is a key determinant of liver zonation. Cell Rep. 13, 1757–1764 (2015).' References 48–56 have been renumbered accordingly. Furthermore, a new sentence citing this reference has been added at the end of the first paragraph in the Discussion: 'A recent report that was published during the final revision of our manuscript suggests a role for pericentrally confined RSPO3 in metabolic liver zonation48.' These changes have been made in the online versions of the Article.
Competing interests
: All authors except S.J.F., L.B., L.M.T., M.H.H., D.C. and M.T.D. are employed by and/or shareholders of Novartis Pharma AG.
